← Back to all resources

🧬 Evidence-Based NAD+ and Aging Resources — NMN, NR, Sirtuin Research & Protocols

Last Updated Evidence-Based Contributions Welcome License: MIT

A comprehensive, evidence-based collection of NAD+ boosters evidence, sirtuin activation research, NMN vs NR clinical comparisons, dosing protocols, cost analysis, and curated PubMed databases. Built for anyone serious about understanding the science of cellular energy and aging — not supplement marketing hype.

For the complete consumer-friendly deep-dive, see the HealthSecrets NAD+ evidence guide at HealthSecrets.com.

> **Quick Answer / TL;DR** > > - **NAD+ levels decline ~50% between ages 40 and 60**, driving mitochondrial dysfunction, impaired DNA repair, and reduced sirtuin activity — hallmarks of biological aging [1] > - **NMN and NR both raise NAD+ levels** in humans at 500–1,000mg daily doses, though a 2025 PRISMA review found functional healthspan outcomes remain inconclusive [2] > - **Sirtuins (SIRT1-7) are NAD+-dependent enzymes** that regulate DNA repair, inflammation, and metabolism — their declining activity with age is a core mechanism of aging [3] > - **A 2026 Nature study** found NR and NMN raise whole-blood NAD+ comparably and enhance microbial growth via nicotinic acid production in the gut [4] > - **Lifestyle NAD+ boosters** — exercise, fasting, and caloric restriction — activate NAMPT and AMPK, supporting endogenous NAD+ production without supplements [5] > - **Safety profiles are favorable** in trials up to 12 months, but long-term human data on lifespan extension is still lacking [2]

📋 Table of Contents

What Is NAD+ and Why Does It Matter for Aging?

NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme required for over 500 enzymatic reactions in the human body, including mitochondrial energy production, DNA repair, and epigenetic regulation. NAD+ levels decline approximately 50% between ages 40 and 60, and this decline is now recognized as a key driver of multiple aging hallmarks [1].

The connection between NAD+ and aging was cemented when Imai and Guarente demonstrated in 2014 that supplementing key NAD+ intermediates could restore NAD+ levels and ameliorate age-associated pathophysiologies in animal models [3]. Since then, human clinical trials have confirmed that oral NAD+ precursors effectively raise circulating NAD+ levels, though translating this biochemical change into measurable healthspan benefits remains an active area of research.

What makes NAD+ particularly important is its position at the crossroads of multiple aging pathways. It serves as the essential co-substrate for sirtuins (DNA repair and gene silencing enzymes), PARPs (DNA damage response), and CD38 (immune signaling). When NAD+ drops, all three systems compete for a shrinking pool — and cellular maintenance suffers.

NAD+ Biosynthesis Pathways

Pathway Starting Molecule Key Enzyme Tissue Distribution Relevance
Salvage pathway Nicotinamide (NAM) NAMPT Ubiquitous — dominant pathway Recycles ~85% of cellular NAD+
Preiss-Handler pathway Nicotinic acid (NA/niacin) NAPRT Liver, kidney, intestine Dietary niacin → NAD+
De novo pathway Tryptophan IDO/TDO, QPRT Liver (primary) Amino acid → NAD+ (inefficient)
NR kinase pathway Nicotinamide riboside (NR) NRK1/NRK2 Muscle, liver, brain, heart Supplement entry point
NMN pathway Nicotinamide mononucleotide (NMN) NMNAT1/2/3 Ubiquitous One step from NAD+

Why NAD+ Declines With Age

Factor Mechanism Impact
CD38 upregulation Immune enzyme that degrades NAD+ increases with chronic inflammation Largest contributor to age-related NAD+ decline [6]
NAMPT decline Rate-limiting salvage enzyme expression drops with age Reduced NAD+ recycling capacity
PARP hyperactivation Accumulated DNA damage triggers increased PARP activity Consumes more NAD+ for repair
Chronic inflammation “Inflammaging” drives CD38 expression in immune and fat tissue Creates a vicious cycle of depletion
Circadian disruption NAMPT is clock-regulated; poor sleep disrupts its rhythm Reduced overnight NAD+ replenishment

📖 Further reading: For the full breakdown of NAD+ biology and practical aging strategies, see the HealthSecrets NAD+ evidence guide.

How Do NMN and NR Compare as NAD+ Precursors?

Both NMN and NR effectively raise NAD+ levels in humans, but they differ in their biochemical pathways, regulatory status, clinical evidence depth, and gut microbiome interactions. A landmark 2026 study in Nature Metabolism by Christen et al. directly compared NR, NMN, and niacin in humans and found that NR and NMN raise whole-blood NAD+ comparably at chronic dosing, while also enhancing gut microbial growth through nicotinic acid production [4].

NR currently has a deeper clinical trial portfolio — it received FDA GRAS (Generally Recognized as Safe) status and has been studied in over 20 published human trials. NMN, being one enzymatic step closer to NAD+ in the biosynthesis chain, has a theoretical efficiency advantage but fewer completed human trials. The practical difference for most people may be minimal.

I was genuinely surprised to find that the gut microbiome angle is more important than most NAD+ discussions acknowledge. Both NR and NMN are partially converted to nicotinic acid by gut bacteria before absorption, meaning your microbiome composition may influence how well these supplements work for you [4].

Head-to-Head Comparison

Feature NMN NR Niacin (NA) Niacinamide (NAM)
Conversion steps to NAD+ 1 (via NMNAT) 2 (NRK → NMNAT) 3 (via Preiss-Handler) 2 (via salvage)
Human clinical trials 12+ published 20+ published Extensive (decades) Limited for NAD+
FDA/regulatory status Dietary supplement (US) GRAS (US) OTC drug/supplement OTC/supplement
Typical dose 250–1,000mg/day 300–1,000mg/day 500–2,000mg/day 500–1,500mg/day
NAD+ elevation 30–50% at 500mg [7] Up to 2.7-fold at 2,000mg [8] Significant (dose-dependent) Moderate
Flushing risk None None High (dose-dependent) None
Stability Stable in powder form Less stable in blood Stable Stable
Cost (30-day supply) $30–80 $30–60 $5–15 $5–10
Gut microbiome effect Enhances microbial growth [4] Enhances microbial growth [4] Direct pathway Minimal reported

Key Clinical Findings by Precursor

NMN (Nicotinamide Mononucleotide):

NR (Nicotinamide Riboside):

Clinical Trial Database — NAD+ Boosters Evidence

A curated database of the most significant human clinical trials for NAD+ precursors.

Study Year Precursor Dose Duration Key Finding Evidence Grade
Christen et al. (Nature Metabolism) 2026 NR, NMN, NA 1,000mg Chronic NR and NMN comparably raise NAD+; enhance gut microbial growth via NA production A
PRISMA Systematic Review 2025 NR, NMN Various Various Consistent biochemical engagement; functional outcomes heterogeneous A
Yoshino et al. (Science) 2021 NMN 250mg 10 weeks Improved muscle insulin sensitivity in prediabetic women A
Martens et al. (Nat. Comm.) 2018 NR 1,000mg 6 weeks 60% NAD+ increase; reduced aortic stiffness and blood pressure trends A
Liao et al. 2021 NMN 1,250mg 6 weeks Improved aerobic capacity in middle-aged runners B
Airhart et al. (PLoS ONE) 2017 NR 500-1,000mg 8 days Dose-dependent NAD+ elevation; well-tolerated B
Dollerup et al. (Am J Clin Nutr) 2018 NR 2,000mg 12 weeks Raised NAD+ in obese men; no significant change in insulin sensitivity B
Remie et al. (Obesity) 2020 NR 1,000mg 6 weeks Modest improvements in body composition and sleep in obese adults B
Elhassan et al. (Cell Reports) 2019 NR 1,000mg 3 weeks Increased NAD+ in skeletal muscle of older adults; altered muscle mitochondrial metabolism A
Katayoshi et al. 2023 NMN 250mg 12 weeks Improved sleep quality and fatigue in older adults B

Evidence Grades: A = Randomized controlled trial or systematic review/meta-analysis. B = Well-designed cohort or pilot study. C = Case reports or preliminary findings.

What Role Do Sirtuins Play in the Aging Process?

Sirtuins (SIRT1-7) are a family of NAD+-dependent deacylase enzymes that function as master regulators of cellular stress resistance, DNA repair, inflammation, and metabolic homeostasis. As NAD+ levels decline with age, sirtuin activity drops — and this reduced activity is directly linked to accelerated aging in both animal models and human tissues [3][13].

The sirtuin-NAD+ connection was a landmark discovery. Imai et al. showed that caloric restriction — the most robust lifespan-extending intervention known — works partly through increased NAD+ availability and sirtuin activation. This finding opened the door to pharmacological approaches: if you can restore NAD+ levels, you can reactivate sirtuins without starving yourself.

A fascinating 2024 study in Pharmacological Research identified a new class of SIRT1 activators that work independently of NAD+, suggesting future therapies might bypass NAD+ decline entirely [14]. But for now, maintaining NAD+ levels remains the most practical approach to supporting sirtuin function.

The Seven Mammalian Sirtuins

Sirtuin Location Primary Function NAD+ Dependence Key Aging Relevance
SIRT1 Nucleus, cytoplasm Deacetylation of histones, p53, NF-κB, PGC-1α High Metabolic regulation, inflammation control, DNA repair
SIRT2 Cytoplasm Tubulin deacetylation, cell cycle regulation Moderate Cell division integrity, myelination
SIRT3 Mitochondria Deacetylation of mitochondrial proteins High Mitochondrial energy production, oxidative stress defense
SIRT4 Mitochondria ADP-ribosylation, lipoamidase Moderate Fatty acid oxidation, amino acid metabolism
SIRT5 Mitochondria Desuccinylation, demalonylation, deglutarylation Moderate Urea cycle, ketone body production
SIRT6 Nucleus Histone H3 deacetylation, DNA double-strand break repair High Genomic stability, telomere maintenance, glucose metabolism
SIRT7 Nucleolus Histone H3K18 deacetylation, rRNA regulation Moderate Ribosome biogenesis, stress response

Sirtuin-Activating Compounds (STACs)

Compound Primary Target Mechanism Evidence Grade Notes
Resveratrol SIRT1 Allosteric activation (lowers Km for substrates) B Synergistic with NAD+ precursors; bioavailability challenges
NAD+ precursors (NMN/NR) All sirtuins Restore co-substrate availability A Most broadly effective approach
Fisetin SIRT1, SIRT3 Activates sirtuins + senolytic properties B Dual mechanism — sirtuin activation and senescent cell clearance
Pterostilbene SIRT1 Resveratrol analogue with 4x better bioavailability B More stable, better absorbed than resveratrol
Honokiol SIRT3 Mitochondrial sirtuin activation B Crosses blood-brain barrier; neuroprotective potential

NAD+ Dosing Protocols — Evidence-Based Recommendations

The most commonly studied and effective dosing range for NAD+ precursors is 500–1,000mg daily, taken in the morning on an empty stomach. Clinical trials consistently show dose-dependent NAD+ elevation at these levels, with NR at 1,000mg daily raising NAD+ by approximately 60% in healthy adults [11].

There is no universally agreed-upon “best” protocol — optimal dosing likely depends on age, health status, baseline NAD+ levels, and individual metabolism. The protocols below are synthesized from published clinical data.

Beginner Protocol (Conservative Start)

Week Supplement Dose Timing Notes
1-2 NMN or NR 250mg Morning, empty stomach Assess tolerance
3-4 NMN or NR 500mg Morning, empty stomach Standard maintenance dose
5+ NMN or NR 500–1,000mg Morning, empty stomach Titrate based on response

Advanced Longevity Stack

Supplement Dose Timing Purpose Evidence Grade
NMN 500–1,000mg Morning, empty stomach Primary NAD+ precursor B
TMG (Trimethylglycine) 500–1,000mg With NMN Methyl donor — offsets potential methyl depletion from NAD+ metabolism B
Resveratrol (trans-) 500mg Morning, with fat source SIRT1 activator; synergistic with NMN B
Vitamin D3 2,000–4,000 IU Morning, with fat Immune and metabolic cofactor A
Omega-3 (EPA+DHA) 2–3g With meals Anti-inflammatory baseline A

Cycling Considerations

Some practitioners recommend cycling NAD+ precursors (e.g., 5 days on, 2 days off) to prevent potential downregulation of salvage pathway enzymes. This approach is theoretically reasonable but has not been validated in human clinical trials. Most published studies use continuous daily dosing.

Cost Analysis — NAD+ Supplements Compared

NAD+ supplementation costs range from under $10/month for niacin to over $100/month for premium NMN formulations. Understanding cost-per-milligram and cost-per-NAD+-unit helps make rational purchasing decisions.

Supplement Monthly Cost (est.) Cost/Day NAD+ Elevation Cost-Effectiveness
Niacin (NA) 1,000mg $5–10 $0.17–0.33 Significant ⭐⭐⭐⭐⭐ (best value, but flushing)
Niacinamide 1,000mg $5–10 $0.17–0.33 Moderate ⭐⭐⭐⭐
NR (Tru Niagen) 300mg $30–45 $1.00–1.50 Moderate-High ⭐⭐⭐
NR 1,000mg $60–90 $2.00–3.00 High ⭐⭐⭐
NMN 500mg $25–50 $0.83–1.67 Moderate-High ⭐⭐⭐
NMN 1,000mg $40–80 $1.33–2.67 High ⭐⭐⭐
IV NAD+ infusion $250–1,000/session N/A Acute spike ⭐ (insufficient evidence for routine use)

Quality Testing: What to Look For

Can You Boost NAD+ Naturally Without Supplements?

Yes — exercise, fasting, caloric restriction, and specific dietary patterns all increase NAD+ biosynthesis through NAMPT upregulation and AMPK activation. In fact, lifestyle interventions may be more effective than supplements for sustained NAD+ maintenance because they address the root causes of decline rather than just the symptom [5].

Exercise is the most potent natural NAD+ booster. Both aerobic and resistance training increase NAMPT expression — the rate-limiting enzyme in the NAD+ salvage pathway. A single bout of moderate exercise can transiently increase NAD+ levels, while chronic training creates lasting adaptations in NAD+ metabolism.

Lifestyle NAD+ Boosters — Evidence Summary

Intervention Mechanism NAD+ Impact Evidence Grade
Aerobic exercise (150+ min/week) NAMPT upregulation, AMPK activation Sustained increase in muscle NAD+ A
Resistance training (2+ days/week) NAMPT expression, mitochondrial biogenesis Increased muscle NAD+ and sirtuin activity A
Intermittent fasting (16:8) AMPK activation, sirtuin upregulation Cyclical NAD+ replenishment A
Caloric restriction (10-20%) NAMPT upregulation, reduced CD38 activity Significant long-term NAD+ preservation A
Heat stress (sauna, 3-4x/week) Heat shock protein activation, NAD+-related pathways Emerging evidence for NAD+ support B
Quality sleep (7-8 hours) NAMPT is circadian-regulated; sleep maintains rhythm Preserves overnight NAD+ production cycle A
Cold exposure Activates brown adipose tissue and SIRT3 Increased mitochondrial NAD+ utilization B

Dietary Sources of NAD+ Precursors

Food NAD+ Precursor Amount per Serving Notes
Chicken breast (3 oz) Niacin (NA) 11.4mg Richest common dietary source
Tuna (3 oz) Niacin 8.6mg Also provides omega-3
Turkey (3 oz) Niacin + tryptophan 10mg niacin Double NAD+ pathway contribution
Mushrooms (1 cup) Niacin + NR traces 3.5mg niacin One of few plant sources of NR
Edamame (1 cup) NMN traces ~1.9mg NMN Highest NMN food source identified
Broccoli (1 cup) NMN traces ~0.25-1.12mg NMN Modest but consistent NMN content
Avocado (1 medium) NMN traces ~0.36-1.60mg NMN Also provides healthy fats
Cow’s milk (1 cup) NR traces ~3.9µmol NR Naturally occurring NR source

Dietary NMN/NR content is orders of magnitude lower than supplement doses, so food alone cannot replicate the NAD+ elevation seen in clinical trials. Dietary sources contribute to baseline NAD+ maintenance but not therapeutic-level restoration.

Safety and Contraindications

NAD+ precursors (NMN and NR) have demonstrated favorable safety profiles across multiple clinical trials, with the most comprehensive review being a 2025 PRISMA systematic review that found both well-tolerated at doses up to 2,000mg daily over weeks to months [2]. However, long-term safety data beyond 12 months is limited.

Known Side Effects

Precursor Common Side Effects Frequency Severity
NMN Mild GI discomfort, headache Uncommon Mild
NR Mild GI discomfort, nausea, fatigue Uncommon Mild
Niacin (NA) Flushing, itching, GI upset, liver enzyme elevation Common Mild to moderate
Niacinamide (NAM) GI discomfort, liver enzyme elevation at high doses Uncommon Mild

Contraindications and Cautions

⚠️ Important: IV NAD+ infusions lack adequate safety data from controlled trials. A 2025 systematic review found no eligible outcome trials evaluating intravenous NAD+ for anti-aging indications [2]. Use extreme caution with IV protocols.

## Frequently Asked Questions **Q: What is NAD+ and why does it decline with age?** **A:** NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme involved in over 500 metabolic reactions, including DNA repair and mitochondrial energy production. NAD+ levels decline approximately 50% between ages 40 and 60, primarily due to increased CD38 enzyme activity driven by chronic inflammation and reduced NAMPT expression [1][6]. **Q: Is NMN or NR better for boosting NAD+ levels?** **A:** Both effectively raise NAD+ in humans. NR has more published human trials and FDA GRAS status. NMN is one enzymatic step closer to NAD+. A 2026 *Nature Metabolism* study found both raise whole-blood NAD+ comparably at chronic dosing and both enhance gut microbial growth [4]. Choose based on cost, availability, and personal tolerance. **Q: What dosage of NAD+ precursors should you take?** **A:** Clinical trials typically use 250–1,000mg daily for both NMN and NR. NR at 1,000mg twice daily can increase whole-blood NAD+ up to 2.7-fold [8]. Start at 250mg daily and titrate upward over 2-4 weeks. Take in the morning on an empty stomach for optimal absorption. **Q: How do sirtuins connect to NAD+ and aging?** **A:** Sirtuins (SIRT1-7) are NAD+-dependent enzymes regulating DNA repair, inflammation, metabolism, and stress resistance. As NAD+ declines with age, sirtuin activity drops, accelerating aging. Restoring NAD+ reactivates sirtuins — this is the primary rationale behind NAD+ precursor supplementation [3][13]. **Q: Are NAD+ supplements safe for long-term use?** **A:** NR and NMN have demonstrated favorable safety profiles in clinical trials lasting up to 12 months. A 2025 PRISMA systematic review confirmed both are generally well tolerated at doses up to 2,000mg daily [2]. Common mild side effects include GI discomfort and headache. Long-term studies beyond 12 months are still needed. **Q: Can you boost NAD+ naturally without supplements?** **A:** Yes. Exercise increases NAD+ biosynthesis via NAMPT upregulation — both aerobic and resistance training are effective. Caloric restriction and intermittent fasting activate AMPK and sirtuins. Foods rich in niacin (chicken, tuna, mushrooms) provide NAD+ precursors through diet, though at levels far below supplement doses [5]. **Q: What is the current state of NAD+ clinical research?** **A:** A 2025 PRISMA systematic review found oral NR and NMN consistently raise NAD+ metabolites and are well tolerated, but effects on functional healthspan outcomes remain heterogeneous and often null [2]. Multiple Phase 2 trials are ongoing for metabolic syndrome, long-COVID, and cognitive decline. The field is promising but not yet proven for lifespan extension.

Disclaimer

This repository is for educational purposes only. The information provided does not constitute medical advice. NAD+ precursor supplementation has not been proven to extend human lifespan. Clinical evidence for healthspan benefits is emerging but not yet conclusive. Individual responses to supplementation vary significantly. Consult a qualified healthcare professional before starting any supplement protocol, especially if you have existing health conditions or take medications.

References

  1. Imai, S., & Guarente, L. “NAD+ and sirtuins in aging and disease.” Trends in Cell Biology, 2014. https://doi.org/10.1016/j.tcb.2014.04.002
  2. “NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence.” Ageing Research Reviews, 2025. https://doi.org/10.1016/j.arr.2025.02.662
  3. Imai, S., & Guarente, L. “It takes two to tango: NAD+ and sirtuins in aging/longevity control.” npj Aging, 2016. https://doi.org/10.1038/npjamd.2016.17
  4. Christen, S., et al. “The differential impact of three different NAD+ boosters on human microbiota and NAD+ metabolism.” Nature Metabolism, 2026. https://doi.org/10.1038/s42255-025-01421-8
  5. Shade, C. “The Science Behind NMN — A Stable, Reliable NAD+ Activator and Anti-Aging Molecule.” Integrative Medicine, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7238909/
  6. Chini, C.C.S., et al. “CD38 dictates age-related NAD decline and mitochondrial dysfunction.” Cell Metabolism, 2020. https://doi.org/10.1016/j.cmet.2020.11.006
  7. Yi, L., et al. “The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults.” GeroScience, 2023. https://doi.org/10.1007/s11357-022-00705-1
  8. Trammell, S.A.J., et al. “Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.” Nature Communications, 2016. https://doi.org/10.1038/ncomms12948
  9. Yoshino, M., et al. “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.” Science, 2021. https://doi.org/10.1126/science.abe9985
  10. Liao, B., et al. “Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners.” Journal of the International Society of Sports Nutrition, 2021. https://doi.org/10.1186/s12970-021-00442-4
  11. Martens, C.R., et al. “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” Nature Communications, 2018. https://doi.org/10.1038/s41467-018-03421-7
  12. “Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial.” eClinicalMedicine, 2025. https://doi.org/10.1016/j.eclinm.2025.103084
  13. Sinclair, D.A., & Guarente, L. “Small-Molecule Allosteric Activators of Sirtuins.” Annual Review of Pharmacology and Toxicology, 2014. https://doi.org/10.1146/annurev-pharmtox-010611-134657
  14. “Discovery and characterization of a new class of NAD+-independent SIRT1 activators.” Pharmacological Research, 2024. https://doi.org/10.1016/j.phrs.2024.107247
  15. Bonkowski, M.S., & Sinclair, D.A. “Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds.” Nature Reviews Molecular Cell Biology, 2016. https://doi.org/10.1038/nrm.2016.93
  16. Cantó, C., et al. “NAD+ Metabolism and the Control of Energy Homeostasis.” Cell Metabolism, 2015. https://doi.org/10.1016/j.cmet.2015.05.001
  17. Rajman, L., Chwalek, K., & Sinclair, D.A. “Therapeutic Potential of NAD-Boosting Molecules.” Cell Metabolism, 2018. https://doi.org/10.1016/j.cmet.2018.02.011
  18. Braidy, N., et al. “Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases.” Antioxidants & Redox Signaling, 2019. https://doi.org/10.1089/ars.2017.7269
  19. Mehmel, M., et al. “Nicotinamide Riboside — The Current State of Research and Therapeutic Uses.” Nutrients, 2020. https://doi.org/10.3390/nu12061616
  20. Nadeeshani, H., et al. “Nicotinamide mononucleotide (NMN) as an anti-aging health product.” Food Bioscience, 2022. https://doi.org/10.1016/j.fbio.2021.101482

Further Reading

© HealthSecrets.com — Evidence-based health guides. For informational purposes only. Not medical advice.